A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus Patients

Clinical trial NCT00349427 · COMPLETED

Trial details

NCT number: NCT00349427
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus Diabetes Mellitus, Type 2

Start date: 2005-10-01
Enrollment: 256

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.